Mustang Bio, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 5.19 million compared to USD 16.69 million a year ago. Basic loss per share from continuing operations was USD 0.46 compared to USD 2.06 a year ago.
Market Closed -
Other stock markets
|
Pre-market 09:10:45 am | |||
0.5605 USD | -34.07% | 0.506 | -9.72% |
Jun. 20 | Mustang Bio to Raise $2.5 Million From Share Offering | MT |
Jun. 20 | Mustang Bio Expects $2.5 Million Gross Proceeds From Registered Direct Offering, Private Placement | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.48% | 15.79M | |
+15.85% | 122B | |
+18.91% | 113B | |
+7.31% | 22.84B | |
-18.63% | 20.72B | |
-15.27% | 16.51B | |
-13.76% | 16.39B | |
-43.53% | 15.83B | |
+1.75% | 13.49B | |
+28.07% | 11.67B |
- Stock Market
- Equities
- MBIO Stock
- News Mustang Bio, Inc.
- Mustang Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024